USANA Health Sciences (USNA) Competitors

$18.00 +0.04 (+0.22%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$17.92 -0.08 (-0.44%)

As of 05/15/2026 06:40 PM Eastern

USNA vs. NATR, NUS, MED, VERU, and EL

Should you buy USANA Health Sciences stock or one of its competitors? MarketBeat compares USANA Health Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with USANA Health Sciences include Nature's Sunshine Products (NATR), Nu Skin Enterprises (NUS), Medifast (MED), Veru (VERU), and Estee Lauder Companies (EL). These companies are all part of the "personal products" industry.

How does USANA Health Sciences compare to Nature's Sunshine Products?

Nature's Sunshine Products (NASDAQ:NATR) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Nature's Sunshine Products has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market.

Nature's Sunshine Products currently has a consensus price target of $35.00, indicating a potential upside of 57.52%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, equities analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nature's Sunshine Products has higher earnings, but lower revenue than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30

79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Nature's Sunshine Products had 6 more articles in the media than USANA Health Sciences. MarketBeat recorded 7 mentions for Nature's Sunshine Products and 1 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 1.19 beat USANA Health Sciences' score of 0.50 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nature's Sunshine Products	4.06%	14.67%	9.27%
USANA Health Sciences	0.96%	6.21%	4.50%

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

Nu Skin Enterprises has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.20	$160.20M	$1.10	5.58
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Nu Skin Enterprises had 3 more articles in the media than USANA Health Sciences. MarketBeat recorded 4 mentions for Nu Skin Enterprises and 1 mentions for USANA Health Sciences. USANA Health Sciences' average media sentiment score of 0.50 beat Nu Skin Enterprises' score of 0.29 indicating that USANA Health Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
USANA Health Sciences	0.96%	6.21%	4.50%

Summary

Nu Skin Enterprises beats USANA Health Sciences on 10 of the 14 factors compared between the two stocks.

How does USANA Health Sciences compare to Medifast?

Medifast (NYSE:MED) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

In the previous week, Medifast had 6 more articles in the media than USANA Health Sciences. MarketBeat recorded 7 mentions for Medifast and 1 mentions for USANA Health Sciences. Medifast's average media sentiment score of 0.74 beat USANA Health Sciences' score of 0.50 indicating that Medifast is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medifast	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.5% of Medifast shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 3.7% of Medifast shares are owned by insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Medifast has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

USANA Health Sciences has a net margin of 0.96% compared to Medifast's net margin of -5.78%. USANA Health Sciences' return on equity of 6.21% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	-5.78%	-4.80%	-3.83%
USANA Health Sciences	0.96%	6.21%	4.50%

USANA Health Sciences has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79M	0.36	-$18.67M	-$1.83	N/A
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30

Medifast currently has a consensus price target of $12.00, indicating a potential downside of 4.34%. Given Medifast's higher probable upside, equities research analysts plainly believe Medifast is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

USANA Health Sciences beats Medifast on 8 of the 14 factors compared between the two stocks.

How does USANA Health Sciences compare to Veru?

USANA Health Sciences (NYSE:USNA) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

In the previous week, Veru had 11 more articles in the media than USANA Health Sciences. MarketBeat recorded 12 mentions for Veru and 1 mentions for USANA Health Sciences. Veru's average media sentiment score of 0.75 beat USANA Health Sciences' score of 0.50 indicating that Veru is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veru	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has a net margin of 0.96% compared to Veru's net margin of 0.00%. USANA Health Sciences' return on equity of 6.21% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Veru	N/A	-54.72%	-39.09%

USANA Health Sciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Veru has a beta of -1.19, indicating that its stock price is 219% less volatile than the broader market.

USANA Health Sciences has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30
Veru	$16.89M	2.01	-$22.73M	-$1.26	N/A

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 47.2% of Veru shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 14.2% of Veru shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Veru has a consensus price target of $23.00, suggesting a potential upside of 990.05%. Given Veru's stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

USANA Health Sciences beats Veru on 9 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Estee Lauder Companies?

USANA Health Sciences (NYSE:USNA) and Estee Lauder Companies (NYSE:EL) are both personal products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

In the previous week, Estee Lauder Companies had 4 more articles in the media than USANA Health Sciences. MarketBeat recorded 5 mentions for Estee Lauder Companies and 1 mentions for USANA Health Sciences. Estee Lauder Companies' average media sentiment score of 0.78 beat USANA Health Sciences' score of 0.50 indicating that Estee Lauder Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Estee Lauder Companies	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

USANA Health Sciences has a net margin of 0.96% compared to Estee Lauder Companies' net margin of -1.67%. Estee Lauder Companies' return on equity of 20.66% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Estee Lauder Companies	-1.67%	20.66%	4.15%

USANA Health Sciences has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Estee Lauder Companies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

USANA Health Sciences has higher earnings, but lower revenue than Estee Lauder Companies. Estee Lauder Companies is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30
Estee Lauder Companies	$14.83B	1.96	-$1.13B	-$0.70	N/A

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 55.2% of Estee Lauder Companies shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 13.1% of Estee Lauder Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Estee Lauder Companies has a consensus price target of $100.68, suggesting a potential upside of 25.51%. Given Estee Lauder Companies' stronger consensus rating and higher probable upside, analysts clearly believe Estee Lauder Companies is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Estee Lauder Companies	2 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.52

Summary

Estee Lauder Companies beats USANA Health Sciences on 12 of the 17 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$331.96M	$3.00B	$6.38B	$22.77B
Dividend Yield	N/A	1.97%	2.81%	4.12%
P/E Ratio	38.30	17.57	20.66	29.73
Price / Sales	0.36	267.37	555.40	23.46
Price / Cash	4.35	57.31	42.43	24.78
Price / Book	0.61	4.33	9.87	4.60
Net Income	$10.76M	$72.19M	$3.57B	$1.07B
7 Day Performance	-5.26%	-3.06%	0.23%	-2.27%
1 Month Performance	-10.43%	-5.08%	-2.54%	-1.66%
1 Year Performance	-40.50%	36.79%	33.54%	21.95%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	2.5095 of 5 stars	$18.00 +0.2%	N/A	-40.5%	$331.96M	$925.26M	38.30	1,570
NATR Nature's Sunshine Products	4.175 of 5 stars	$22.18 -8.5%	$35.00 +57.8%	+49.4%	$426.08M	$480.14M	20.16	850	Positive News High Trading Volume
NUS Nu Skin Enterprises	3.0365 of 5 stars	$6.66 -7.1%	N/A	-19.2%	$344.59M	$1.49B	6.05	2,800	High Trading Volume
MED Medifast	1.7273 of 5 stars	$12.37 -1.7%	$12.00 -3.0%	-10.4%	$139.99M	$385.79M	N/A	870
VERU Veru	3.4779 of 5 stars	$2.21 -1.3%	$22.50 +918.1%	-59.4%	$35.95M	$16.89M	N/A	230	News Coverage Earnings Report Analyst Forecast Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. NATR, NUS, MED, VERU, and EL

How does USANA Health Sciences compare to Nature's Sunshine Products?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Summary

How does USANA Health Sciences compare to Medifast?

Summary

How does USANA Health Sciences compare to Veru?

Summary

How does USANA Health Sciences compare to Estee Lauder Companies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. NATR, NUS, MED, VERU, and EL

How does USANA Health Sciences compare to Nature's Sunshine Products?

Which has more risk and volatility, NATR or USNA?

Do analysts recommend NATR or USNA?

Which has higher valuation & earnings, NATR or USNA?

Do insiders and institutionals believe in NATR or USNA?

Does the media prefer NATR or USNA?

Is NATR or USNA more profitable?

Summary

How does USANA Health Sciences compare to Nu Skin Enterprises?

Which has more volatility & risk, NUS or USNA?

Do analysts recommend NUS or USNA?

Which has stronger valuation and earnings, NUS or USNA?

Do institutionals and insiders believe in NUS or USNA?

Does the media prefer NUS or USNA?

Is NUS or USNA more profitable?

Summary

How does USANA Health Sciences compare to Medifast?

Does the media prefer MED or USNA?

Do institutionals and insiders believe in MED or USNA?

Which has more volatility & risk, MED or USNA?

Is MED or USNA more profitable?

Which has stronger valuation and earnings, MED or USNA?

Do analysts recommend MED or USNA?

Summary

How does USANA Health Sciences compare to Veru?

Does the media refer more to USNA or VERU?

Is USNA or VERU more profitable?

Which has more risk & volatility, USNA or VERU?

Which has better earnings and valuation, USNA or VERU?

Do institutionals & insiders have more ownership in USNA or VERU?

Do analysts rate USNA or VERU?

Summary

How does USANA Health Sciences compare to Estee Lauder Companies?

Does the media refer more to USNA or EL?

Is USNA or EL more profitable?

Which has more volatility and risk, USNA or EL?

Which has stronger earnings & valuation, USNA or EL?

Do insiders and institutionals have more ownership in USNA or EL?

Do analysts rate USNA or EL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools